FUJIFILM (4901) ESG Briefing summary
Event summary combining transcript, slides, and related documents.
ESG Briefing summary
6 Jun, 2025Design strategy and management
Embedding design into all business areas drives innovation and sustainable growth, with design management integrated at the executive level and involved from product development to brand promotion.
The Design Center reports directly to the CEO, ensuring design is central to value creation for key products.
CLAY Studio, established as a creative hub, fosters collaboration across internal teams and external partners, stimulating creativity and innovation.
Fujifilm's design philosophy emphasizes faithful, human-oriented design that transforms unspoken user needs into products.
The company’s design management has been recognized with top awards, including the Minister of Economy, Trade and Industry Award for Design Management.
Product and technology innovation
Proprietary technologies from photographic film have been leveraged to create new products in diverse fields, including cosmetics, medical devices, and digital cameras.
The instax series evolved from analog to digital, expanding global reach and user experience.
Medical systems benefit from user-centric design, such as lightweight X-ray systems and intuitive diagnostic kits, improving workflow and accessibility.
AI technology brand REILI enhances medical diagnostics and business innovation, driving significant sales growth and operational efficiency.
Open & Close strategy accelerates product commercialization by combining internal development with external partnerships.
Awards and external recognition
Fujifilm has consistently won top global design awards, including Good Design, Red Dot, iF, and IDEA, leading in total awards for several years.
Design excellence is seen as product excellence, with awards validating the positive impact on users.
The partnership between design and development is highlighted as a key to turning innovative ideas into market needs.
Latest events from FUJIFILM
- Record revenue and profit guidance upgrades driven by Electronics and Imaging growth.4901
Q3 20265 Feb 2026 - Aiming for ¥500bn revenue and market leadership in key semiconductor materials by FY2030.4901
Investor Update10 Dec 2025 - Record H1 and Q2 results driven by imaging and bio CDMO growth, with raised revenue guidance.4901
Q2 20266 Nov 2025 - Operating income surged 21% on flat revenue, with Imaging leading growth and tariff risks ahead.4901
Q1 20266 Aug 2025 - Record Q1 growth and raised outlook driven by electronics and imaging.4901
Q1 202513 Jun 2025 - Record revenue and operating income, but net income declined on higher non-operating costs.4901
Q2 202513 Jun 2025 - Record earnings and robust outlook fueled by Electronics and Imaging growth.4901
Q3 20259 Jun 2025 - Record highs in revenue and profit, led by Imaging, Electronics, and Bio CDMO growth.4901
Q4 20256 Jun 2025